Are peptides legal in Iowa?

Can a Iowa resident get peptides by telehealth?

Iowa Board of Medicine rule 481-655.9 (renumbered from 653-13.11 when Iowa's licensing boards moved into the Department of Inspections, Appeals, and Licensing; current version effective May 21, 2025) defines telemedicine to include asynchronous store-and-forward, remote monitoring, and real-time interactive services, but not care delivered only by audio-only telephone, email, fax, or mail. A physician treating a patient located in Iowa must hold an active Iowa license (subrule 655.9(3)). A valid physician-patient relationship may be established through telemedicine when the standard of care does not require an in-person encounter (655.9(7)), and before prescribing the physician must collect the relevant history and perform an exam when medically necessary; an adaptive, interactive, and responsive online interview can qualify, but a static internet questionnaire does not, and subrule 655.9(21) expressly prohibits prescribing based solely on an internet request or static questionnaire. Asynchronous prescribing is therefore allowed when the asynchronous intake is interactive and meets the standard of care. [2] [3]

How does the Iowa pharmacy board treat compounding?

The Iowa Board of Pharmacy, now housed in the Department of Inspections, Appeals, and Licensing, regulates pharmacies under Iowa Code chapter 155A and Board rules. Effective July 16, 2025 (after a 70-day legislative delay that was lifted in August 2025), the Board rescinded its former rules at 657 IAC, including the old compounding chapter 20, and replaced them with 481 IAC chapters 550 to 557. Compounding is now rule 481-552.22: preparations compounded under section 503A must meet USP General Chapter 795 (2023) for nonsterile and 797 (2023) for sterile compounds, and compounding a preparation that is essentially a copy of an FDA-approved drug is prohibited unless the prescriber documents a clinically significant difference for the individual patient or the approved product is listed as in shortage on the FDA drug shortages database. Iowa has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Iowa Code 155A.13A requires any pharmacy outside Iowa that delivers, dispenses, or distributes prescription drugs to an Iowa patient by any method to obtain an Iowa nonresident pharmacy license, and the applicant must submit its most recent inspection report, less than two years old, conducted while the pharmacy was operating and covering every part of its business that will be used in Iowa, along with evidence of corrective action for any deficiencies. [1] [4] [5] [6] [7]

Can you get compounded GLP-1s in Iowa?

Iowa's telemedicine rule allows asynchronous GLP-1 programs only if the online intake is adaptive and interactive rather than a static form, and the rule also bars physicians from steering prescriptions to a specific pharmacy in exchange for any benefit (subrule 655.9(19)), which matters for bundled telehealth and pharmacy offers. [3] [10]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Iowa?

Find a provider in Iowa

• Compounding pharmacies in Iowa
• Clinics in Iowa
• Telehealth providers in Iowa

Is it legal to buy research peptides in Iowa?

Only Iowa-licensed pharmacies, including nonresident pharmacies licensed under Iowa Code 155A.13A, may dispense prescription drugs to Iowa patients. [4] [11]

Peptide-specific notes for Iowa

Compare: Semaglutide vs tirzepatide.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.